Eurofarma Laboratórios S.A. Share Price

Stocks

EUFA3

BREUFAACNOR4

Market Closed - Sao Paulo			5-day change	1st Jan Change
- ^BRL	-.--%		-.--%	-

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Latest news: Eurofarma Laboratórios S.A.

08-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-15	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-26	Eurofarma Laboratórios S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
01-23	Bavarian Nordic A/S Signs Distribution Agreement with Eurofarma to Expand Access to Chikungunya Vaccine in Brazil	CI
12-10	Psivant Therapeutics, Inc. announced that it has received $47.5 million in funding from YK Bioventures, Samsara BioCapital LLC, Roivant Sciences Ltd., LSV Capital Management, LLC, Eurofarma Laboratórios S.A. and other investors	CI
11-14	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
21/10/25	Mentis Care, Inc Appoints Hassan Kotob as Chief Executive Officer	CI
21/10/25	SK Biopharmaceuticals Co., Ltd. Launches Joint Venture with Eurofarma for Ai-Based Epilepsy Management Platform	CI
21/08/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/05/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
26/03/25	Eurofarma Laboratórios S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
16/03/25	Eurofarma Laboratórios S.A. acquired 60% stake in Klibra Agenciamento de Marcas e Negócios for approximately BRL 160 million.	CI
14/11/24	Eurofarma Laboratórios S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024	CI

More news

Managers and Directors: Eurofarma Laboratórios S.A.

Manager	Title	Age	Since
Marco Billi CEO	Chief Executive Officer	-	22/11/2021
Alexandre Mendes Palhares IRC	Investor Relations Contact	40	22/11/2021

Director	Title	Age	Since
Maurízio Billi CHM	Chairman	-	22/11/2021
Cristina Presz Palmaka de Luca BRD	Director/Board Member	58	22/11/2021
Juliana Rozenbaum Munemori BRD	Director/Board Member	50	31/12/2018

More insiders

Latest insider transactions

Date	Insider	Type	Quantity	% Market Cap.
10/01/25	Controlling Shareholder Brazilian	Buy	1,644,236	0.1665%
04/12/24	Controlling Shareholder Brazilian	Sell	15,405,639	1.5600%
04/12/24	Controlling Shareholder Brazilian	Buy	15,405,639	1.5600%

Transaction History

Financials

	2024	2025
Net sales	10.97B 2.12B 1.85B 1.75B 1.59B 2.98B 204B 2.99B 20.95B 8.09B 104B 7.98B 7.8B 333B	12.48B 2.42B 2.11B 1.99B 1.81B 3.38B 232B 3.4B 23.83B 9.19B 118B 9.07B 8.87B 379B
Net income	117M 22.71M 19.8M 18.7M 16.98M 31.81M 2.18B 31.94M 224M 86.42M 1.11B 85.3M 83.41M 3.56B	571M 111M 96.48M 91.1M 82.72M 155M 10.62B 156M 1.09B 421M 5.4B 416M 406M 17.37B
Net Debt	-	-

* Estimated data More financial data

Company Profile

Employees

13,000

Sector

More about the company